Background {#Sec1}
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The high-flow nasal cannula (HFNC) system has gained great popularity owing to several advantages: greater comfort and better tolerability \[[@CR1]\], improved mucociliary clearance \[[@CR2]\], decreased nasal airway resistance \[[@CR3]\], a "wash-out" effect of dead space \[[@CR4]\], generation of positive airway pressure \[[@CR5]\], and ability to reliably deliver fixed concentrations of oxygen and other therapeutic gases, including inhaled nitric oxide \[[@CR6]\]. When compared to noninvasive positive-pressure ventilation with a tight-fitting mask, the greater comfort and tolerability of HFNC becomes a great advantage in otherwise uncooperative children. Indeed, the HFNC therapy has been widely used for children in various clinical scenarios \[[@CR7]--[@CR9]\]. Despite the widespread use of HFNC in the pediatric intensive care unit, the physiological and clinical impact of HFNC therapy on the pediatric patient with respiratory distress after cardiac surgery has not been thoroughly investigated \[[@CR10]\].

Main text {#Sec2}
=========

It seems logical to use HFNC as a primary therapy for post-extubation respiratory distress after pediatric cardiac surgery. First, low cardiac output syndrome (LCOS) is commonly encountered after congenital heart surgery and contributes to significant postoperative morbidity and mortality \[[@CR11]\]. In the presence of LCOS, increased work of breathing (WOB) is poorly tolerated; excessively negative intrathoracic pressure increases systemic ventricular afterload, while increased diaphragmatic oxygen consumption reduces oxygen delivery to vital organs \[[@CR12], [@CR13]\]. In this situation, HFNC therapy helps to decrease afterload by providing positive pressure and by abating sympathetic nervous system activity via unloading of respiratory and cardiovascular work \[[@CR5], [@CR12]\]. Second, an upper airway obstruction (UAO) is relatively common after pediatric cardiac surgery and has been implicated as an important contributor to extubation failure in this population \[[@CR14]--[@CR16]\]. UAO increases negative swings of intrathoracic pressure and increases WOB, thereby imposing an undue burden on a recovering myocardium and further complicating LCOS; HFNC therapy could alleviate the WOB and large negative swings of intrathoracic pressure.

In addition to these advantages, however, consideration must be given to its diverse effects on hemodynamics in patients after congenital heart surgery, given the complex respiratory and cardiac pathophysiology in these patients. The positive pressure generated by HFNC can exert different effects on pulmonary vascular resistance (PVR), depending on the lung condition; it may increase PVR as lung volumes rise above functional residual capacity (FRC) in a patient with healthy lungs, but may decrease PVR by restoring FRC and improving alveolar oxygen tension in a patient with pulmonary edema or atelectasis \[[@CR12]\]. Furthermore, the effects of positive pressure on cardiac output (CO) may also differ depending on cardiac function. When the systolic function of the systemic ventricle is impaired, positive pressure by HFNC likely improves CO, as the beneficial effect on systemic ventricular afterload outweighs the potential negative impact on venous return. In a patient with preserved systolic function, however, the negative effects of decreased venous return may predominate, leading to reduced CO \[[@CR12]\].

The effects of HFNC may become even more complex in a patient with a single ventricle \[[@CR17]\]. In parallel circulation, for example, reduction of PVR through maintenance of FRC by HFNC could inadvertently increase the ratio of pulmonary flow to systemic flow, while the benefit of reducing oxygen demand by respiratory muscles and reducing systemic vascular resistance through alleviation of sympathetic nervous system stimulation may outweigh the potential disadvantages. Following the Fontan procedure, the negative effects of positive pressure on venous return and ventricular filling typically predominate over the positive effects on the afterload of the systemic ventricle \[[@CR12]\]. However, when the systolic function is severely depressed, positive pressure may be beneficial, by decreasing afterload and oxygen consumption. In addition, it may decrease PVR by restoring and maintaining FRC in the presence of pulmonary edema or atelectasis.

In this issue of the *Journal*, Shioji et al. reported the physiological impact of HFNC therapy on post-extubation acute respiratory failure in children after various cardiac surgeries. They compared respiratory and hemodynamic parameters before and 1 h after applying HFNC. HFNC therapy significantly decreased respiratory rate, as expected from a physiological study in healthy volunteers \[[@CR5]\] and other studies in adults and children with respiratory distress \[[@CR18], [@CR19]\]. Interestingly, systolic blood pressure (SBP) in the patients with serial circulation significantly decreased after HFNC therapy. We speculate that decreased SBP is a result of reduction in sympathetic activity via unloading respiratory and cardiovascular work, given the fact that heart rate also decreased, albeit not significantly. While the authors used only rudimentary respiratory and hemodynamic parameters when assessing the effect of HFNC, they should be highly commended for their efforts to describe the physiological impact since the single previous report on HFNC therapy in this population examined only changes in arterial blood gas parameters \[[@CR10]\]. Nonetheless, to better design a future study and deepen our understanding, we can gain some insight from previous studies that have utilized various techniques to assess respiratory and hemodynamic parameters. For example, an esophageal balloon catheter and electrical activity of the diaphragm have been utilized to investigate the effects of HFNC on WOB \[[@CR20], [@CR21]\]. Parke et al. used electrical impedance tomography to assess end-expiratory lung volume with varying degrees of gas flow \[[@CR5]\]. Regarding cardiovascular parameters, near-infrared spectroscopy was used to evaluate cerebral circulation while applying HFNC in a patient with Fontan circulation \[[@CR22]\]. Although these modalities to assess respiratory and cardiovascular physiology have their own limitations, they certainly augment the assessment of physiological impact.

The authors also attempted a subgroup analysis of the effect of HFNC based on the cardiac physiologies (serial circulation vs. single ventricle). Besides the limitation of the small sample size, future studies could be improved from other aspects as well. First, the patients could be classified into specific subgroups, not simply into serial circulation and single ventricle groups, by clearly delineating the types of surgery and original cardiac physiology. HFNC therapy may exert different effects depending on the cardiac physiology---systemic to pulmonary shunt vs. bidirectional Glenn operation vs. Fontan operation---or, depending on the preoperative pulmonary hemodynamics, high vs. low pulmonary flow. Habre et al. demonstrated that immediate improvement in lung function after surgical repair of congenital heart disease was seen in children with high pulmonary flow, but not with restricted pulmonary flow \[[@CR23]\]. It would be interesting to know if HFNC therapy exerts different respiratory and hemodynamic effects in these contrasting types of pulmonary circulation. Lastly, the flow rate should be specified, e.g., 2 L/kg/min, or changed according to an a priori protocol, not at the discretion of bedside physicians. Given the evidence of progressive increase in nasopharyngeal airway pressure and end-expiratory lung volume with a higher flow rate \[[@CR5]\], there is likely a flow rate at which the benefit is maximized through optimal cardiopulmonary interactions. Such an optimal flow rate should be sought in future studies.

Conclusion {#Sec3}
==========

Further studies are needed to better understand the effect of HFNC in different cardiac and respiratory physiologies, given their complexity in pediatric patients after cardiac surgery. In the meantime, we should be cognizant of both potential positive and negative effects on hemodynamics when applying and titrating HFNC in this population.
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